Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| SERM10-03232026 | Mar 2026 | 99.9% | Kovera Labs | Endotoxin, Sterility, Heavy metals | Confirmed | View |
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. Sermorelin is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Ion Peptide sell Sermorelin?
Ion Peptide has 9 COAs on file for Sermorelin but no active price listing is currently tracked.
Is Ion Peptide's Sermorelin third-party tested?
Yes — Disclosed Labs has indexed 9 Certificates of Analysis for Ion Peptide's Sermorelin, with the most recent showing 99.9% purity. Ion Peptide holds an overall trust grade of A (92/100) across all 560 COAs on file.
What is Ion Peptide's trust grade for Sermorelin?
Ion Peptide has an overall Disclosed Labs trust grade of A (92/100), computed from 560 COAs across all peptides. The most recent Sermorelin COA was issued by Kovera Labs.
Where is the cheapest Sermorelin?
As of the latest data, Peptide Supply Co. offers Sermorelin at $3.80/mg — compare with Ion Peptide's listing. See the full Sermorelin price comparison.
Is Sermorelin legal to buy?
Sermorelin is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| SERM5-02022026 | Feb 2026 | 99.1% | Freedom Diagnostics | — | Confirmed | View |
| SRM10-01212026 | Jan 2026 | 99.3% | Freedom Diagnostics | — | Confirmed | View |
| SM10-12082025 | Dec 2025 | 98.9% | Freedom Diagnostics | — | Confirmed | View |
| SR15-1125 | Nov 2025 | 99.2% | Freedom Diagnostics | — | Confirmed | View |
| SRM10-1125 | Nov 2025 | 99.3% | Freedom Diagnostics | — | Unverified | View |
| SR1-1025 | Oct 2025 | 99.5% | Freedom Diagnostics | — | Confirmed | View |
| SMO10-05122026 | — | 99.2% | Kovera Labs | Endotoxin, Sterility, Heavy metals | Confirmed | View |
| SERM10-04072026 | — | 99.9% | Kovera Labs | Endotoxin, Sterility, Heavy metals | Confirmed | View |